News

Experts from 13 national bodies, including seven Royal Colleges, have joined forces to launch new practical guidance to support doctors and other health professionals around valproate use in women and girls in their reproductive years.

We have worked with NHS England on a programme to ensure children and young people with a learning disability, autism or both are able to access appropriate medication, and are not prescribed inappropriate psychotropic medication. Find out more and read our full pledge.

A new feature for our 2019 RCPCH Conference and exhibition, these talks will showcase the latest ideas and discoveries in child health.

RCPCH responds to new research which suggests these drugs may alter gut microbes associated with weight gain.

The Department of Health & Social Care has issued urgent guidance relating to supply disruption of Mylan EpiPens for all health care professionals who prescribe, dispense or administer adrenaline auto-injectors.

Our medicines information resource for parents and children is shortlisted for the “Optimisation of Medicines Management” category of the Health Service Journal Award, which celebrates healthcare excellence.

RCPCH Registrar, Dr Mike Linney, says the decision will 'come as a relief for some'. He warns parents in the meantime to not give children unlicensed cannabinoid oil products.

The Medicines for Children team have been awarded funding with their charity partner, WellChild. Here, they discuss what the grant will be used for, and the different that this funding can make.

There have been a number of recent media articles about the use of Calpol® paracetamol in children for treating a fever. The RCPCH urges all parents to take advice from NHS Choices and Medicines for Children when administering medicines to their children.

We offer additional resources to support girls and young women to understand the risks of taking sodium valproate during pregnancy.